We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current VSTM market cap is 182.03M. The company's latest EPS is USD -1.9630 and P/E is -2.03.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -19.34M | -20.29M | -21.31M | -31.14M | -28.06M |
| Net Income | -15.71M | -24.28M | -20M | -27.37M | -33.86M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 17.46M | 88.52M | 2.05M | 2.6M | 0 |
| Operating Income | -132.34M | -49.36M | -61.41M | -72.94M | -92.08M |
| Net Income | -149.21M | -67.73M | -71.2M | -73.81M | -87.37M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 120.88M | 191.76M | 176.15M | 149.72M | 123.54M |
| Total Liabilities | 66.69M | 69.01M | 71.81M | 71.19M | 77.32M |
| Total Equity | 33.03M | 101.59M | 83.18M | 57.37M | 25.06M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 145.05M | 154.35M | 108.66M | 95.05M | 149.72M |
| Total Liabilities | 137.87M | 39.08M | 21.1M | 47.66M | 71.19M |
| Total Equity | 7.17M | 115.27M | 87.56M | 47.39M | 57.37M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -20.29M | -40.19M | -56.78M | -86.46M | -28.31M |
| Investing | -804k | 13.2M | -56.88M | -44.45M | 30.98M |
| Financing | 44.05M | 135.53M | 134.64M | 134.19M | 846k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -138.52M | -33.51M | -53.5M | -63.67M | -86.46M |
| Investing | 89.61M | -47.36M | 87k | 66.19M | -44.45M |
| Financing | -2.44M | 69.63M | 6.89M | 51.78M | 134.19M |
| Market Cap | 182.03M |
| Price to Earnings Ratio | -2.03 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.28 |
| Price to Book Ratio | 2.26 |
| Dividend Yield | - |
| Shares Outstanding | 44.51M |
| Average Volume (1 week) | 746.57k |
| Average Volume (1 Month) | 972.15k |
| 52 Week Change | -36.79% |
| 52 Week High | 14.22 |
| 52 Week Low | 2.10 |
| Spread (Intraday) | 0.13 (3.16%) |
| Company Name | Verastem Inc |
| Address |
corporation trust center 1209 orange st wilmington, delaware 19801 |
| Website | https://www.verastem.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
